Mount Sinai Microbiologist Selected as Revson Senior Fellow in Biomedical Science
Jessica Sook Yuin Ho, PhD, a postdoctoral fellow in microbiology at the Icahn School of Medicine at Mount Sinai, has been selected as a Charles H. Revson Senior Fellow in Biomedical Science by the Charles H. Revson Foundation.
Jessica Sook Yuin Ho, PhD, a postdoctoral fellow in microbiology at the Icahn School of Medicine at Mount Sinai, has been selected as a Charles H. Revson Senior Fellow in Biomedical Science by the Charles H. Revson Foundation. The two-year fellowship is awarded annually to eight exceptionally talented New York City scientists entering their third or fourth year of postdoctoral research.
Intended to help address the need for funding during the critical third and fourth years of training when postdoctoral fellows are finishing their initial projects and establishing themselves as independent researchers, the fellowship attracts applications from dozens of highly qualified candidates from 13 top medical and research institutions. Only a select few are chosen.
Dr. Sook Yuin Ho works in the Marazzi Laboratory in the Department of Microbiology at Icahn Mount Sinai. Her research focuses on a novel viral protein and its role in pathogenesis. She wrote her fellowship application based on a paper she published in Cell in 2020, which focused on the presence of human-chimeric proteins/genes that are generated during influenza A infection. Essentially, she and her colleagues assert that these proteins are not generated by chance during infection, but are actually a means for the virus to explore its genetic potential to encode new genes. Additionally, they posit that these proteins could be suitable targets for future therapeutic or vaccine design for influenza A virus. Dr. Sook Yuin Ho is interested in further characterizing the functions and roles of these proteins in infected cells.
“Most of our high-risk projects depend on the support of private foundations that understand the need to promote transformative discoveries,” said Ivan Marazzi, PhD, Associate Professor of Microbiology at Icahn Mount Sinai. “We are grateful to the Revson Foundation for their recognition of our work and for their support of Dr. Sook Yuin Ho’s important scientific endeavors.”
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across eight hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 11 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2023-2024.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.